Polyrizon Ltd. (PLRZ)

$1.55 -0.09 (-5.49%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,429,814
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorp...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 374 0120
Address:
5 Ha-Tidhar Street, Ra'anana, Israel
949Jaguar123
949Jaguar123 Nov. 14 at 12:45 AM
$PLRZ What the heck is going on with the SP , every day it's gone down for the last 2 weeks ? I was green with this for the longest time .
1 · Reply
StMartinBr
StMartinBr Nov. 13 at 8:02 PM
$PLRZ strong avoid
1 · Reply
Joshr1371
Joshr1371 Nov. 12 at 9:29 PM
$PLRZ to hold or to sell…..hmmm
2 · Reply
DrewSerick
DrewSerick Nov. 10 at 1:47 AM
Made my month green for sure 🔥 I recommend you FOLLOW @ICEMAN_ALERTS - One of the best traders i know 💎 Always in point with his entries. Check him out Also holding some $IXHL $USAR $PLRZ $BLMZ 🚀
0 · Reply
Joby099
Joby099 Nov. 7 at 2:03 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Joby099
Joby099 Nov. 7 at 2:21 AM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
xcapenstyle
xcapenstyle Nov. 6 at 10:27 PM
$PLRZ I'm waiting
1 · Reply
CantAffordMe
CantAffordMe Nov. 6 at 9:50 PM
$PLRZ they should come up with a protective anal spray for their shareholders
0 · Reply
Joby099
Joby099 Nov. 6 at 8:37 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Mountain_Skis
Mountain_Skis Nov. 6 at 7:00 PM
$PLRZ back over $1 eod?
1 · Reply
Latest News on PLRZ
Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation

Nov 6, 2025, 8:55 AM EST - 8 days ago

Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation

Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy

Oct 6, 2025, 8:21 AM EDT - 5 weeks ago

Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

Sep 19, 2025, 8:15 AM EDT - 2 months ago

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Sep 12, 2025, 7:26 AM EDT - 2 months ago

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

Polyrizon Regains Compliance with Nasdaq Listing Requirements

Aug 14, 2025, 8:14 AM EDT - 3 months ago

Polyrizon Regains Compliance with Nasdaq Listing Requirements

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Jul 15, 2025, 7:55 AM EDT - 4 months ago

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Jun 12, 2025, 7:32 AM EDT - 5 months ago

Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics

Polyrizon Announces Receipt of Nasdaq Delisting Notice

May 23, 2025, 4:15 PM EDT - 6 months ago

Polyrizon Announces Receipt of Nasdaq Delisting Notice

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

May 21, 2025, 7:10 AM EDT - 6 months ago

Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

May 13, 2025, 7:45 AM EDT - 6 months ago

Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Apr 25, 2025, 7:37 AM EDT - 7 months ago

Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Apr 11, 2025, 4:15 PM EDT - 7 months ago

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Apr 2, 2025, 9:05 AM EDT - 8 months ago

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Apr 1, 2025, 4:09 PM EDT - 8 months ago

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement

Polyrizon Ltd. Announces $17.0 Million Private Placement

Mar 31, 2025, 9:32 AM EDT - 8 months ago

Polyrizon Ltd. Announces $17.0 Million Private Placement

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Mar 27, 2025, 8:25 AM EDT - 8 months ago

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Mar 25, 2025, 4:04 PM EDT - 8 months ago

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Mar 14, 2025, 8:35 AM EDT - 8 months ago

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Mar 13, 2025, 7:51 AM EDT - 8 months ago

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Mar 11, 2025, 4:27 PM EDT - 8 months ago

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Mar 10, 2025, 7:47 AM EDT - 8 months ago

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Jan 30, 2025, 5:55 AM EST - 10 months ago

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Jan 23, 2025, 6:40 AM EST - 10 months ago

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Dec 30, 2024, 6:25 AM EST - 11 months ago

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Dec 19, 2024, 7:22 AM EST - 11 months ago

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Dec 18, 2024, 6:25 AM EST - 11 months ago

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Dec 13, 2024, 6:25 AM EST - 1 year ago

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Dec 2, 2024, 8:02 AM EST - 1 year ago

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Oct 30, 2024, 1:50 PM EDT - 1 year ago

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Oct 30, 2024, 10:28 AM EDT - 1 year ago

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

Oct 28, 2024, 7:02 PM EDT - 1 year ago

Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”

949Jaguar123
949Jaguar123 Nov. 14 at 12:45 AM
$PLRZ What the heck is going on with the SP , every day it's gone down for the last 2 weeks ? I was green with this for the longest time .
1 · Reply
StMartinBr
StMartinBr Nov. 13 at 8:02 PM
$PLRZ strong avoid
1 · Reply
Joshr1371
Joshr1371 Nov. 12 at 9:29 PM
$PLRZ to hold or to sell…..hmmm
2 · Reply
DrewSerick
DrewSerick Nov. 10 at 1:47 AM
Made my month green for sure 🔥 I recommend you FOLLOW @ICEMAN_ALERTS - One of the best traders i know 💎 Always in point with his entries. Check him out Also holding some $IXHL $USAR $PLRZ $BLMZ 🚀
0 · Reply
Joby099
Joby099 Nov. 7 at 2:03 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Joby099
Joby099 Nov. 7 at 2:21 AM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
xcapenstyle
xcapenstyle Nov. 6 at 10:27 PM
$PLRZ I'm waiting
1 · Reply
CantAffordMe
CantAffordMe Nov. 6 at 9:50 PM
$PLRZ they should come up with a protective anal spray for their shareholders
0 · Reply
Joby099
Joby099 Nov. 6 at 8:37 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Mountain_Skis
Mountain_Skis Nov. 6 at 7:00 PM
$PLRZ back over $1 eod?
1 · Reply
layLOW120
layLOW120 Nov. 6 at 2:19 PM
$PLRZ this isn't the big news from the FDA so I will wait for that rocket.
1 · Reply
NetNinja
NetNinja Nov. 6 at 2:13 PM
$PLRZ Nothing but a Dead Poop Bounce.
0 · Reply
STKH
STKH Nov. 6 at 2:13 PM
$PLRZ
0 · Reply
jamestocklover
jamestocklover Nov. 6 at 2:10 PM
$ALTO $4+ SOON. PURE ACCUMULATION. HUUUGGGE SQUEEZE. GROSS PROFIT $18M. REVENUE, $241M. 🔥🚀💯 $FTEL $BIYA $BHF $PLRZ https://ca.finance.yahoo.com/news/alto-ingredients-inc-alto-q3-050721277.html
0 · Reply
DARKP00L
DARKP00L Nov. 6 at 2:08 PM
$PLRZ this stock is seeing a surge in interest. Market volatility might ensue!
0 · Reply
premarketmaker
premarketmaker Nov. 6 at 2:07 PM
$PLRZ get in early because once this moves over $1.30+, we are going to $1.57 range guys - if we get there, I will provide next levels. $1.14 is bulls breakthrough target to achieve above
1 · Reply
bowlerhatsftw
bowlerhatsftw Nov. 6 at 2:07 PM
$PLRZ dang, i think im done for the day. That was like a 5 minute play
0 · Reply
bowlerhatsftw
bowlerhatsftw Nov. 6 at 2:06 PM
$PLRZ fading it now. Is a true nano but i will not linger in thjs
0 · Reply
YouVSYou
YouVSYou Nov. 6 at 2:05 PM
$PLRZ 1.08/1.14/1.18/1.22 W pattern neckline 1.75
0 · Reply
GimliSonofGloin
GimliSonofGloin Nov. 6 at 2:04 PM
$PLRZ Interesting to see this stay floating in this range before open after the news. It's not absolutely huge news, but hopefully see some more volume come in at open.
0 · Reply
mortimerT
mortimerT Nov. 6 at 2:04 PM
$PLRZ so how does it stop the virus from going in thru your mouth? This is a nasal gel. This is ridiculous.
1 · Reply